CXS
Click for more information
0.00% 70.0¢ chemgenex pharmaceuticals ltd

Ann: Omacetaxine European rights licensed to Hosp, page-4

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. Raider1969
    312 Posts.
    clock Created with Sketch.
    14/12/09
    09:27
    Post #: 6038874
    re: Ann: Omacetaxine European rights licensed... you would like to think so

    undoubtedly some will use the next rise to get out
    CXS Price at posting: 93.0¢ Sentiment: ST Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Sierra Nevada raises $2M for silver exploration at Blackhawk
right-arrow Created with Sketch.
NEWS Significant resource upgrade and maiden ore reserve established, highlighting growth potential at Kanmantoo Copper Mine
right-arrow Created with Sketch.
NEWS First-ever treatment for Rett syndrome approved in Canada, opening new possibilities for patients and boosting potential royalty payments—discover more about DAYBUE™'s breakthrough
right-arrow Created with Sketch.
NVU Nanoveu commences crucial benchmark testing for System-on-aChip (SoC) Semiconductor technology
right-arrow Created with Sketch.
NEWS Canyon-1H well drilling advancing as planned, with promising results observed and key milestones on track for completion by late October
right-arrow Created with Sketch.
NEWS Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CXS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.